Fig. 2From: Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinomaAhR interacts with multiple other signalling pathways. AhR activates other cytosolic proteins, including β-catenin, Smads, ERK, p38MAPK and JNKBack to article page